Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Reconstruction, Sinai Hospital of Baltimore, 2401 West Belvedere Avenue, Baltimore, MD 21215, USA.
Clin Orthop Relat Res. 2011 Jun;469(6):1582-8. doi: 10.1007/s11999-010-1629-5.
Young patients with osteonecrosis (ON) treated with THA often have suboptimal function and radiographic failure with eventual revision. Resurfacing may be an option because of potentially increased functionality and decreased radiographic failure, although neither has been confirmed in the literature.
QUESTIONS/PURPOSES: We therefore compared the clinical scores and radiographic failures of resurfacing patients 25 years or younger with osteonecrosis with those for patients with ON treated with THA.
We identified 17 patients (20 resurfaced hips) who were 25 years or younger and treated by resurfacing for ON. Mean followup was 62 months (range, 32-103 months). This group was matched by gender, age, BMI, and followup to 16 patients (20 hips) treated with THA with a mean 61 month followup (range, 34-88 months). Additionally, the group was compared to 78 patients (87 hips) with ON over age 25 who underwent resurfacing during the same time with a mean followup of 61 months (range, 27-112 months).
The mean Harris score improved from 48 points preoperatively to 93 points with a 100% 7.5 year survivorship in the young resurfacing group. In the THA cohort, the mean score improved from 44 points preoperatively to 94 points postoperatively, with a 93.3% 7.5 year survivorship; similar to the results for all resurfacing patients. Radiographs did not reveal malalignment or progressive radiolucencies in any cohort.
At approximately 5 year followup, young resurfacing patients were similar to other resurfacing patients and standard THA patients regarding clinical ratings and radiographic failures.
接受 THA 治疗的年轻骨坏死(ON)患者的功能通常不佳,影像学失败最终需要翻修。由于功能可能增加,影像学失败减少,表面置换可能是一种选择,尽管这在文献中尚未得到证实。
问题/目的:因此,我们比较了 25 岁或以下接受骨坏死表面置换治疗的患者与接受 THA 治疗的 ON 患者的临床评分和影像学失败率。
我们确定了 17 名(20 个表面置换髋关节)年龄在 25 岁或以下的 ON 患者接受表面置换治疗。平均随访时间为 62 个月(范围,32-103 个月)。该组在性别、年龄、BMI 和随访时间上与接受 THA 治疗的 16 名患者(20 个髋关节)匹配,平均随访时间为 61 个月(范围,34-88 个月)。此外,该组与同期接受表面置换治疗的 78 名(87 个髋关节)25 岁以上的 ON 患者进行了比较,平均随访时间为 61 个月(范围,27-112 个月)。
年轻表面置换组的平均 Harris 评分从术前的 48 分提高到术后的 93 分,7.5 年生存率为 100%。在 THA 组中,平均评分从术前的 44 分提高到术后的 94 分,7.5 年生存率为 93.3%;与所有表面置换患者的结果相似。在任何一组中,影像学检查均未发现失对线或进行性透亮线。
在大约 5 年的随访中,年轻的表面置换患者在临床评分和影像学失败方面与其他表面置换患者和标准 THA 患者相似。